Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:bromfenac
|
| gptkbp:approvalYear |
2016
|
| gptkbp:ATCCode |
gptkb:S01BC11
|
| gptkbp:concentration |
0.075%
|
| gptkbp:contraindication |
hypersensitivity to bromfenac or NSAIDs
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
gptkb:eye_drops
|
| gptkbp:indication |
treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery
|
| gptkbp:manufacturer |
gptkb:Sun_Pharmaceutical_Industries
|
| gptkbp:mechanismOfAction |
nonsteroidal anti-inflammatory drug (NSAID)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
topical (ophthalmic)
|
| gptkbp:sideEffect |
headache
blurred vision eye pain increased intraocular pressure |
| gptkbp:bfsParent |
gptkb:Sun_Pharma
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
BromSite
|